Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1991-7-15
|
pubmed:abstractText |
Three patients with clinical suspicion of pheochromocytoma were studied with metaiodobenzylguanidine (MIBG) labeled with I-123 or I-131. In these three patients, marked uptake of the radiopharmaceutical was demonstrated in tissues that were subsequently proven not to be of neural crest origin. Furthermore, extensive biochemical evaluations and long-term followup definitively excluded pheochromocytoma in all three. Therefore, these three cases represent unexpected "false-positive" MIBG uptake.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0363-9762
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
16
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
239-42
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:2044316-3-Iodobenzylguanidine,
pubmed-meshheading:2044316-Adrenal Gland Neoplasms,
pubmed-meshheading:2044316-Adult,
pubmed-meshheading:2044316-False Positive Reactions,
pubmed-meshheading:2044316-Female,
pubmed-meshheading:2044316-Humans,
pubmed-meshheading:2044316-Iodine Radioisotopes,
pubmed-meshheading:2044316-Iodobenzenes,
pubmed-meshheading:2044316-Male,
pubmed-meshheading:2044316-Middle Aged,
pubmed-meshheading:2044316-Pheochromocytoma
|
pubmed:year |
1991
|
pubmed:articleTitle |
Unusual causes of I-131 metaiodobenzylguanidine uptake in non-neural crest tissue.
|
pubmed:affiliation |
Department of Nuclear Medicine, Assaf Harofeh Medical Center, Zerifin, Israel.
|
pubmed:publicationType |
Journal Article,
Case Reports
|